Editors Note August 30, 2011

Summer is winding down, but activity is heating up in the world of healthcare and emerging life sciences.  OneMedSentinel continues coverage of some of the most promising companies and technologies, as well as innovative approaches to funding the growth economy. In this issue:

Citibank files to raise $100 million to fund Global Silicon Valley Capital [GSVC]. This comes on the back of a $50 million financing in May to provide investors an opportunity to own equity in promising technology companies. GSVC success could have an impact on growth company finance in a broad sense as it provides a new model in a dying IPO ecosystem. (see interview)

Diagnostics Columnist joins OneMedSentinel. Peter Winter founded the Canadian Biotechnology Report before it was acquired by Burrill. He then served as Editorial Director for Burrill and Company for 8 years. His periodic column will include summaries of important developments and financings  in the global diagnostics field.

OneMedForum 2012 announced it has begun selection of companies that will be presenting at it’s 5th Annual Forum. Several of the firms can also been seen at the Rodman and Renshaw conference. Learn their location and presentation times.

Wound Management [WNDM] closes major distribution deal for lead product. Their CellerateRX wound care product is experiencing rapid market acceptance.

Other upcoming Events:  Proactive Investors Healthcare Forum set for September 15th. Presentations from  International Stem Cell Corp, Immunocellular, and OncoSec Corporation.  See event listing to register.

The comments are closed.